Krishnan V - Search Results

1

The BIM deletion polymorphism potentiates the survival of leukemia stem and progenitor cells and impairs response to targeted therapies.

Yu M, Nah GSS, Krishnan V, Sulaimi FNB, Ng KP, Wang C, Bhatt S, Chuah C, Bergstrom DE, Ong ST. Yu M, et al. Among authors: krishnan v. Leukemia. 2025 Jan;39(1):134-143. doi: 10.1038/s41375-024-02418-0. Epub 2024 Oct 22. Leukemia. 2025. PMID: 39438588

2

Disruption of Runx1 and Runx3 leads to bone marrow failure and leukemia predisposition due to transcriptional and DNA repair defects.

Wang CQ, Krishnan V, Tay LS, Chin DW, Koh CP, Chooi JY, Nah GS, Du L, Jacob B, Yamashita N, Lai SK, Tan TZ, Mori S, Tanuichi I, Tergaonkar V, Ito Y, Osato M. Wang CQ, et al. Among authors: krishnan v. Cell Rep. 2014 Aug 7;8(3):767-82. doi: 10.1016/j.celrep.2014.06.046. Epub 2014 Jul 24. Cell Rep. 2014. PMID: 25066130 Free article.

3

RCA2: a scalable supervised clustering algorithm that reduces batch effects in scRNA-seq data.

Schmidt F, Ranjan B, Lin QXX, Krishnan V, Joanito I, Honardoost MA, Nawaz Z, Venkatesh PN, Tan J, Rayan NA, Ong ST, Prabhakar S. Schmidt F, et al. Among authors: krishnan v. Nucleic Acids Res. 2021 Sep 7;49(15):8505-8519. doi: 10.1093/nar/gkab632. Nucleic Acids Res. 2021. PMID: 34320202 Free PMC article.

4

Integrating genetic and epigenetic factors in chronic myeloid leukemia risk assessment: toward gene expression-based biomarkers.

Krishnan V, Kim DDH, Hughes TP, Branford S, Ong ST. Krishnan V, et al. Haematologica. 2022 Feb 1;107(2):358-370. doi: 10.3324/haematol.2021.279317. Haematologica. 2022. PMID: 34615339 Free PMC article. Review.

5

Validation and refinement of a RUNX1 mutation-associated gene expression signature in blast crisis chronic myeloid leukemia.

Lee KL, Ko TK, Saw NYL, Javed A, Hillmer AM, Chuah C, Krishnan V, Ong ST. Lee KL, et al. Among authors: krishnan v. Leukemia. 2022 Mar;36(3):892-896. doi: 10.1038/s41375-022-01508-1. Epub 2022 Feb 4. Leukemia. 2022. PMID: 35121847 Free PMC article. No abstract available.

6

A single-cell atlas identifies pretreatment features of primary imatinib resistance in chronic myeloid leukemia.

Krishnan V, Schmidt F, Nawaz Z, Venkatesh PN, Lee KL, Ren X, Chan ZE, Yu M, Makheja M, Rayan NA, Lim MGL, Cheung AMS, Bari S, Chng WJ, Than H, Ouyang J, Rackham O, Tan TZ, Hwang WYK, Chuah C, Prabhakar S, Ong ST. Krishnan V, et al. Blood. 2023 Jun 1;141(22):2738-2755. doi: 10.1182/blood.2022017295. Blood. 2023. PMID: 36857629 Free article.

7

Chronic Inflammation Deters Natural Killer Cell Fitness and Cytotoxicity in Myeloid Leukemia.

Kuznetsova V, Krishnan V, Costa A, Ren X, Ricketts TD, Patel SB, Connelly AN, Goel P, Knapp JP, Franceski AM, Luca F, de Figueiredo-Pontes LL, Bhatia R, Prabhakar S, Ong ST, Welner RS. Kuznetsova V, et al. Among authors: krishnan v. Blood Adv. 2024 Nov 21:bloodadvances.2024014592. doi: 10.1182/bloodadvances.2024014592. Online ahead of print. Blood Adv. 2024. PMID: 39571169

8

The RUNX Family of Proteins, DNA Repair, and Cancer.

Krishnan V. Krishnan V. Cells. 2023 Apr 7;12(8):1106. doi: 10.3390/cells12081106. Cells. 2023. PMID: 37190015 Free PMC article. Review.

9

RUNX3 loss turns on the dark side of TGF-beta signaling.

Krishnan V, Ito Y. Krishnan V, et al. Oncoscience. 2017 Nov 28;4(11-12):156-157. doi: 10.18632/oncoscience.382. eCollection 2017 Nov. Oncoscience. 2017. PMID: 29344546 Free PMC article. No abstract available.

10

A Regulatory Role for RUNX1, RUNX3 in the Maintenance of Genomic Integrity.

Krishnan V, Ito Y. Krishnan V, et al. Adv Exp Med Biol. 2017;962:491-510. doi: 10.1007/978-981-10-3233-2_29. Adv Exp Med Biol. 2017. PMID: 28299675 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,040 results

Search Page

Filters